|
Summary Information: Terns Pharmaceuticals Inc. Common Stock NASDAQ:TERN |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns’ programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients.
__The following are links to various summary and news pages for __Terns Pharmaceuticals Inc. Common Stock [ TERN ]. __Note: Some Links might not have information for the company. |
|